共 50 条
- [21] Evaluation of blood-based PRO-C3 testing as a diagnostic marker for staging liver fibrosis: A systematic review and meta-analysisJOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2023, 38 (07) : 1018 - 1027Liu, MengluQiu, HanyingZhang, WenyanMei, TingtingTang, ShanGao, YuxueZhu, YanqiuHuang, XiaojieYu, Haibin
- [22] A marker of true type III collagen formation (Pro-C3) predicts rapid fibrosis progression in post-liver transplant patientsHEPATOLOGY, 2015, 62 : 908A - 908ANielsen, Mette J.Zimmermann, TimKarsdal, Morten A.Leeming, Diana J.Schuppan, Detlef
- [23] TRUE COLLAGEN TYPE III FORMATION (PRO-C3) IS PREDICTIVE OF OUTCOME IN HCV PATIENTS WITH ADVANCED LIVER FIBROSIS WITHIN THE TRENT STUDYJOURNAL OF HEPATOLOGY, 2016, 64 : S719 - S720Leeming, D. J.Dolman, G.Nielsen, M. J.Karsdal, M. A.Patel, K.Irving, W.Guha, I. N.
- [24] Validation of scores of PRO-C3 to predict liver-related events in alcohol-related liver diseaseLIVER INTERNATIONAL, 2023, 43 (07) : 1486 - 1496Johansen, StineIsraelsen, Mads F.Villesen, IdaTorp, Nikolaj J.Nielsen, MetteKjaergaard, Maria P.Lindvig, Katrine D.Hansen, CamillaAndersen, Peter N.Rasmussen, DitlevDetlefsen, Sonke J.Leeming, DianaThiele, MajaKarsdal, MortenKrag, AleksanderAnastasiadou, EmaArumugam, ManimozhianBork, PeerHansen, TorbenHenrar, RolandIsraelsen, HansKarsdal, MortenLegido-Quigley, CristinaMelberg, Hans OlavThiele, MajaTrebicka, JonelKrag, AleksanderMann, MathiasMatthijnssens, Jelle
- [25] Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver DiseaseBIOMEDICINES, 2021, 9 (12)Mak, Anne LindeLee, Jennyvan Dijk, Anne-MariekeVali, YasamanAithal, Guruprasad P.Schattenberg, Joern M.Anstee, Quentin M.Brosnan, M. JuliaZafarmand, Mohammad HadiRamsoekh, DewkoemarHarrison, Stephen A.Nieuwdorp, MaxBossuyt, Patrick M.Holleboom, Adriaan G.
- [26] PRO-C3 BUT NOT PC3X IS INCREASED WITH ADVANCED FIBROSIS STAGE IN A LONGITUDINAL COHORT OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD) PATIENTSHEPATOLOGY, 2020, 72 : 939 - 939Knochel, JaneKechagias, StergiosBergenholm, LinneaLiljeblad, MathiasDaniels, Samuel JosephLeeming, Diana J.Nasre, PatrikCarlsson, BjornEkstedt, MattiasHansson, Sara
- [27] PRO-C3 determined active fibrogenesis is a predictor of liver-related outcomes in patients with chronic hepatitis CJOURNAL OF HEPATOLOGY, 2024, 80 : S737 - S737Skovgaard, EmilieMoller, ThomasKarsdal, MortenLeeming, DianaPatel, Keyur
- [28] BIOSYNTHESIS OF PRO-C3, A PRECURSOR OF 3RD COMPONENT OF COMPLEMENTJOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (03): : 759 - 765BRADE, VHALL, RECOLTEN, HR
- [29] Pro-C3 in combination with clinical parameters is associated with severity of histological features of non-alcoholic steatohepatitis and fibrosisHEPATOLOGY, 2017, 66 : 1107A - 1108ALeeming, Diana J.Nielsen, Mette J.Goodman, Zachary D.Friedman, Scott L.Lefebvre, EricSeyedka-Zemi, StarWiens, BrianFischer, LaurentKarsdal, Morten A.Sanyal, Arun J.Ratziu, Vlad
- [30] Serum PRO-C3 is useful for risk prediction and fibrosis assessment in MAFLD with chronic kidney disease in an Asian cohortLIVER INTERNATIONAL, 2024, 44 (05) : 1129 - 1141Tang, Liang-JieSun, Dan-QinSong, Sherlot JuanYip, Terry Cheuk-FungWong, Grace Lai-HungZhu, Pei-WuChen, Sui-DanKarsdal, MortenLeeming, Diana JulieJiang, PeiWang, CongChen, QiangByrne, Christopher D.Targher, GiovanniEslam, MohammedGeorge, JacobWong, Vincent Wai-SunZheng, Ming-Hua